Instil Bio, Inc.
TIL
$11.49
$0.716.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.12% | 29.33% | 36.72% | 52.50% | 61.85% |
| Total Depreciation and Amortization | -67.66% | -45.62% | -21.60% | -24.10% | -32.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 72.34% | -23.16% | -34.03% | -64.97% | -77.48% |
| Change in Net Operating Assets | 50.30% | -1,619.57% | -219.52% | -39.81% | 29.41% |
| Cash from Operations | 31.47% | 5.93% | 26.33% | 32.10% | 44.60% |
| Capital Expenditure | -- | -- | -- | -- | 99.83% |
| Sale of Property, Plant, and Equipment | -64.67% | -64.59% | -18.37% | -44.38% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.43% | 1.81% | 14.18% | -11.83% | -43.50% |
| Cash from Investing | -44.18% | 12.28% | 51.61% | 31.23% | -8.43% |
| Total Debt Issued | -- | -- | 1,937.13% | 887.43% | -100.00% |
| Total Debt Repaid | -- | -14,012.10% | -14,012.10% | -14,012.10% | 100.00% |
| Issuance of Common Stock | 566.04% | -- | -- | -- | -57.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,489.94% | 1,576.83% | -45.03% | -78.29% | -98.89% |
| Foreign Exchange rate Adjustments | 45.83% | 123.43% | 105.00% | 53.23% | 57.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.29% | 106.55% | 148.10% | 99.82% | 88.93% |